Fundz

Scripta Therapeutics raises $12M in a seed round to find disease-modifying drugs that alter transcription factor activity, led by Oxford Science Enterprises and Apollo Health Ventures.

PRIVATENov 13, 2025

Amount Raised

$12 Million

Round Type

Seed

OxfordBiotechnologyHealth Care

Investors

AlbionVCApollo Health VenturesOxford Science EnterprisesYZR CapitalParkwalk Advisors

Description

Techbio startup Scripta Therapeutics has emerged from stealth with a $12 million seed round. The funding aims to revolutionize drug discovery through a unique approach focusing on transcription factors. The round is backed by Oxford Science Enterprises and Apollo Health Ventures, alongside other investors. Scripta's innovative strategy targets conditions like Alzheimer’s disease.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Scripta Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • CASI Pharmaceuticals raised $5M on December 27, 2025.
  • Initiate raised an undisclosed amount (Private Equity) on December 23, 2025.
  • FONAR raised $41M on December 23, 2025.
  • Vyriad raised $25M (Series B) on December 23, 2025.
  • Kashiv BioSciences raised $72M (Debt Financing) on December 23, 2025.
  • FONAR raised $10M on December 23, 2025.

Who to call at Scripta Therapeutics, and when

A new round usually means Scripta Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Scripta Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Scripta Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Scripta Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Scripta Therapeutics

Location

Oxford, England, United Kingdom

About

Scripta Therapeutics is an Oxford-based techbio company that takes a biology-first approach to discover disease-modifying drugs that modulate transcription factor activity and reprogram biology. We aim to discover and develop therapeutics for neurodegenerative disorders. We are following a unique strategy, based on the concept that transcription factors, the master controllers of gene expression, are core drivers of disease and act as detailed and dynamic maps of disease. Therapeutics that modulate these maps to restore the healthy cell state can be efficiently identified by a data-rich, lab-in-the-loop combination of experimental biology with cutting-edge AI and informatics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Scripta Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Scripta Therapeutics's next move

See what Strategic adds

Scripta Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.